Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iradimed (IRMD) Treasury Shares (2016 - 2025)

Iradimed has reported Treasury Shares over the past 10 years, most recently at $24535.0 for Q4 2025.

  • Quarterly Treasury Shares fell 81.77% to $24535.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $24535.0 through Dec 2025, down 81.77% year-over-year, with the annual reading at $24535.0 for FY2025, 81.77% down from the prior year.
  • Treasury Shares was $1.8 million for Q3 2017 at Iradimed, up from $1.6 million in the prior quarter.
  • Over five years, Treasury Shares peaked at $151337.0 in Q4 2022 and troughed at $24535.0 in Q4 2025.
  • The 5-year median for Treasury Shares is $131182.0 (2021), against an average of $95685.2.
  • The largest YoY upside for Treasury Shares was 81.76% in 2017 against a maximum downside of 84.42% in 2017.
  • A 2-year view of Treasury Shares shows it stood at $10.0 million in 2016, then plummeted by 81.76% to $1.8 million in 2017.
  • Per Business Quant, the three most recent readings for IRMD's Treasury Shares are $24535.0 (Q4 2025), $134580.0 (Q4 2024), and $36792.0 (Q4 2023).